Work

Heterogeneity of intermediate prognosis patients (pts) with metastatic renal cell cancer (mRCC) treated with sunitinib.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.446

Authors: Avishay Sella, M. Dror Michaelson, Ewa M. Matczak, Ronit Simantov, Mariajose Lechuga, Xun Lin, Robert A. Figlin

Institutions: Assaf Harofeh Medical Center, Massachusetts General Hospital, Pfizer (United States), Cedars-Sinai Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591447796

Cites:

Cited by:

Related to: 10